Glasdegib Recruiting Phase 1 / 2 Trials for Leukemia Acute Myeloid Leukemia (AML) / acute, recurrent Myeloid Leukemia / Refractory Acute Myelogenous Leukemia (AML) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT02038777A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies